RecruitingNCT05022446

The Impact of COVID-19 on Pulmonary Procedures

The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey

Sponsor

M.D. Anderson Cancer Center

Enrollment

250 participants

Start Date

Nov 11, 2020

Study Type

OBSERVATIONAL

Conditions

Malignant Solid Neoplasm Hematopoietic and Lymphoid Cell Neoplasm COVID-19 Infection

Summary

This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study surveys pulmonologists (lung doctors) in the United States about how the COVID-19 pandemic has affected how they perform pulmonary (lung-related) procedures. The goal is to understand changes in practice patterns and patient care. **You may be eligible if...** - You are a pulmonologist (lung specialist) who performs pulmonary procedures - You are a member of the American Association of Bronchology and Interventional Pulmonology (AABIP) or the American College of Chest Physicians (ACCP) - You practice in the United States **You may NOT be eligible if...** - You are not a pulmonologist - You do not perform pulmonary procedures - You are not a member of the specified professional organizations Talk to your doctor or professional society to see if this survey study is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.